National Health Investors, Inc. (NHI)
NYSE: NHI · Real-Time Price · USD
69.40
-1.03 (-1.46%)
Jun 8, 2026, 11:34 AM EDT - Market open
National Health Investors Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 146.72 | 140.79 | 136.64 | 134.38 | 65.5 | -20.59 |
Depreciation & Amortization | 88.38 | 83.85 | 74.34 | 72.49 | 78.44 | 14.97 |
Stock-Based Compensation | 5.26 | 5.58 | 4.18 | 4.61 | 8.61 | - |
Other Adjustments | -16.7 | 2.54 | -12.93 | -33.73 | 35.34 | 1.54 |
Change in Receivables | - | - | - | - | - | -0.77 |
Changes in Accounts Payable | 6.93 | 5.49 | 3.29 | 5.93 | 0.43 | 0.19 |
Changes in Accrued Expenses | - | - | - | - | - | 0.98 |
Changes in Unearned Revenue | 2.16 | 1.71 | -1.14 | 0.1 | 0.41 | - |
Changes in Other Operating Activities | -2.8 | 0.06 | -1.9 | -0.71 | -3.53 | -24.64 |
Operating Cash Flow | 243.53 | 236.56 | 207.77 | 184.45 | 185.34 | -28.33 |
Operating Cash Flow Growth | 14.11% | 13.86% | 12.64% | -0.48% | - | - |
Capital Expenditures | -315.41 | -294.03 | -157.93 | -49.56 | -10.99 | -9.22 |
Sale of Property, Plant & Equipment | 6.66 | - | 6.18 | 57.03 | 168.96 | 0 |
Purchases of Investments | -58.03 | -71.11 | -60.41 | -35.63 | -79.8 | - |
Proceeds from Sale of Investments | 76.5 | 92.33 | 19.45 | 13.47 | 119.21 | - |
Other Investing Activities | 3.25 | 3.66 | 0.4 | 3.06 | 0.57 | 0 |
Investing Cash Flow | -297.57 | -269.15 | -192.32 | -11.63 | 197.95 | -9.22 |
Short-Term Debt Issued | 573 | 694 | 449.7 | 364 | 225 | 5.77 |
Short-Term Debt Repaid | -711.2 | -821.2 | -363.5 | -161 | -183 | -8.27 |
Net Short-Term Debt Issued (Repaid) | -138.2 | -127.2 | 86.2 | 203 | 42 | -2.5 |
Long-Term Debt Issued | - | 346.16 | - | 200 | - | - |
Long-Term Debt Repaid | -200.7 | -200.82 | -75.44 | -415.43 | -135.39 | -0.19 |
Net Long-Term Debt Issued (Repaid) | -200.7 | 145.35 | -75.44 | -215.43 | -135.39 | -0.19 |
Issuance of Common Stock | 116.05 | 181.53 | 142.39 | - | - | - |
Repurchase of Common Stock | -4.83 | -0.46 | -5.82 | - | -152.24 | - |
Net Common Stock Issued (Repurchased) | 111.22 | 181.08 | 136.58 | - | -152.24 | - |
Common Dividends Paid | -173.02 | -169.7 | -156.51 | -156.24 | -161.77 | - |
Other Financing Activities | -3.69 | -3.82 | -4.4 | -1.05 | 6.14 | 32.89 |
Financing Cash Flow | -58.29 | 25.71 | -13.57 | -169.72 | -401.25 | 30.2 |
Net Cash Flow | 5.32 | -6.88 | 1.89 | 3.1 | -17.97 | -7.35 |
Free Cash Flow | -71.89 | -57.47 | 49.84 | 134.89 | 174.35 | -37.55 |
Free Cash Flow Growth | - | - | -63.06% | -22.63% | - | - |
FCF Margin | -17.91% | -15.30% | 14.87% | 42.18% | 62.67% | -27.14% |
Free Cash Flow Per Share | -1.51 | -1.22 | 1.13 | 3.11 | 3.89 | -0.82 |
Levered Free Cash Flow | -411.76 | -42.81 | 65.28 | 151.43 | 37.76 | -41.64 |
Unlevered Free Cash Flow | -22.19 | -8.89 | 99.85 | 205.38 | 146 | -37.68 |